Literature DB >> 10835010

Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

F Barbut1, A Richard, K Hamadi, V Chomette, B Burghoffer, J C Petit.   

Abstract

Approximately 15 to 35% of patients with a first episode of Clostridium difficile-associated diarrhea relapse within 2 months. Between 1994 and 1997, strains from 93 hospitalized patients with C. difficile recurrences were fingerprinted by using both serotyping and PCR-ribotyping. The results showed that 48.4% of clinical recurrences were, in fact, reinfections with a different strain of C. difficile. Rates of clinical recurrences could therefore be reduced by implementing strict isolation precautions.

Entities:  

Mesh:

Year:  2000        PMID: 10835010      PMCID: PMC86814          DOI: 10.1128/JCM.38.6.2386-2388.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

2.  Treatment of Clostridium difficile colitis.

Authors:  J G Bartlett
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

3.  Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.

Authors:  S Johnson; A Adelmann; C R Clabots; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

4.  Artifactual variation in randomly amplified polymorphic DNA banding patterns.

Authors:  D L Ellsworth; K D Rittenhouse; R L Honeycutt
Journal:  Biotechniques       Date:  1993-02       Impact factor: 1.993

5.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.

Authors:  P Bidet; F Barbut; V Lalande; B Burghoffer; J C Petit
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

6.  Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables.

Authors:  S E Brooks; R O Veal; M Kramer; L Dore; N Schupf; M Adachi
Journal:  Infect Control Hosp Epidemiol       Date:  1992-02       Impact factor: 3.254

7.  Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping.

Authors:  M Delmée; C Depitre; G Corthier; A Ahoyo; V Avesani
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

9.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment.

Authors:  R Fekety; K H Kim; D Brown; D H Batts; M Cudmore; J Silva
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

View more
  99 in total

1.  Clostridium difficile mixed infection and reinfection.

Authors:  David W Eyre; A Sarah Walker; David Griffiths; Mark H Wilcox; David H Wyllie; Kate E Dingle; Derrick W Crook; Tim E A Peto
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Relapse versus reinfection: surveillance of Clostridium difficile infection.

Authors:  Mini Kamboj; Perminder Khosa; Anna Kaltsas; N Esther Babady; Crystal Son; Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

Review 3.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 4.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Facilely accessible quinoline derivatives as potent antibacterial agents.

Authors:  Peng Teng; Chunhui Li; Zhong Peng; Vanderschouw Anne Marie; Alekhya Nimmagadda; Ma Su; Yaqiong Li; Xingmin Sun; Jianfeng Cai
Journal:  Bioorg Med Chem       Date:  2018-05-22       Impact factor: 3.641

Review 6.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

Review 7.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

8.  Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.

Authors:  Zhiyong Yang; Jeremy Ramsey; Therwa Hamza; Yongrong Zhang; Shan Li; Harris G Yfantis; Dong Lee; Lorraine D Hernandez; Wolfgang Seghezzi; Jamie M Furneisen; Nicole M Davis; Alex G Therien; Hanping Feng
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

9.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

Authors:  D Wultańska; A Banaszkiewicz; A Radzikowski; P Obuch-Woszczatyński; G Młynarczyk; J S Brazier; H Pituch; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.